Cámara-Castillo H, Ibarra-Ponce N

Language: Spanish
References: 10
Page: 83-85
PDF size: 43.32 Kb.

ABSTRACT

Objective: To describe the effectiveness of betametasona phosphate and acetate intra and perilesional as unique therapy in chalazia treatment.
Material and methods: A prospective, longitudinal and experimental study included patients with 4 months evolution chalazia. Betametasone phosphate and acetate (8mg/ml) (celestone soluspan®) was administered in the lesion and its periphery. Sex, age, evolution time, eye, IOP, and subjective and objective (mm) description of the lesion was determined before the procedure and during the follow up at the 1st, 2nd and 6th week.
Results: We studied 60 cases in 38 patients, 18 male and 20 female, range age 26.11 years, evolution time 4.2 months, range size 8.20 mm. The size diminished a range of 3.17 mm the first week, 2.50 mm the 2nd week and 2.4 mm the 6th week. A correlation could be established with this results and the subjective perception of the lesion. There were no IOP variations.
Conclusions: The administration of betametasone phosphate and acetate is an effective treatment alternative for chalazia because of its easy disposal, low cost and satisfactory results.

REFERENCES

1. Ho SY, Lai JS. Subcutaneous steroid injection as treatment for chalazion: prospective case series. Hong Kong Med J 2002; 8(1):18-20.

2. Epstein GA, Putterman AM. Combined excision and drainage with intralesional corticosteroid injection in the treatment of chronic chalazia. Arch Ophthalmol 1988; 106:514-16.

3. Perry HD, Serniuk RA. Conservative treatment of chalazia. Ophthalmology 1980; 87(3):218-21.

4. Khurana AK, Ahluwalia BK, Rajan C. Chalazion therapy. Intralesional steroids versus incisión and curettage. Acta Ophthalmol 1988; 66(3):352-4.

5. Garrett GW, Gillespie ME, Manis BC. Adrenocorticosteroid injection vs. conservative therapy in the treatment of chalazia. Ann Ophthalmol 1988; 20(5):196-198.

6. Kaimbo WA, Ahluwalia BK, Rajan C. Chalazion theraphy. Intralesional steroids versus incisin and curettage. Acta Ophthalmol 1988; 66(3):352-4.

7. Hosal BM, Zilelioglu G. Ocular complication of intralesional corticosteroid injection of a chalazion. Eur J Ophthalmol 2003; 13(9-0):798-9.

8. Shiramizu KM, Kreiger AE, McCannel CA. Severe visual loss caused by ocular peforation during chalazion removal. Am J Ophthalmol 2004; 137(1):204-5.

9. Thomas EL, Laborde RP. Retina and choroidal vascular occlusion following intralesional corticosteroid injection of a chalazion. Ophthalmology 1986; 93(3):405-7.

10. Pizzarello LD, Jakobiec FA, Hofeldt AJ, Podolsky MM, Silvers DN. Intralesional corticosteroid therapy of chalazia. Am J Ophthlmol 1978; 85:818-21.